Showing 921-930 of 8921 results for "".
Cutaneous Oncology in 2024
https://practicaldermatology.com/conferences/maui-derm-2024/cutaneous-oncology-in-2024/20266/Resident Of Distinction Award-winner Banu Farabi, MD, a PGY-3 resident at New York Medical College, talks about a review she attended highlighting the latest therapeutic approaches to treating conditions such as actinic keratosis and several different types of skin cancer, as well as an overview ofSkin Cancer Prevention: Can Laser Therapy Help?
https://practicaldermatology.com/conferences/scale-2023/skin-cancer-prevention-can-laser-therapy-help/20205/Non-ablative fractional laser treatments may dramatically the reduce risk of skin cancer recurrence. Joel L. Cohen, MD, and Mathew M. Avram, MD, JD, discuss the science behind this intriguing finding.DermWireTV: Atopic Dermatitis Pipeline Watch, a Potential New Skin Cancer Treatment; Demystifying Itch, and the Premiere of PA Perspectives
https://practicaldermatology.com/topics/practice-management/dermwiretv-atopic-dermatitis-pipeline-watch-a-potential-new-skin-cancer-treatment-demystifying-itch-and-the-premiere-of-pa-perspectives/20228/Escient Pharmaceuticals, Rapt Therapeutics, and Connect Biopharma each report positive results from early clinical studies in AD. Finnish researchers discover a potential treatment for cutaneous squamous cell carcinoma in an existing chemotherapy drug. Research out of Harvard Medical School links ecBreaking a Sweat: Treating Hyperhidrosis in the COVID-19 Era
https://practicaldermatology.com/series/dermatology-dispatches/breaking-a-sweat-treating-hyperhidrosis-in-the-covid-19-era/19767/Hyperhidrosis patients can be evaluated with telemedicine, says Neal Bhatia, MD. It’s important that these individuals have adequate supplies of their medication for the duration of any stay-at-home orders. In addition, dermatologists should try to distinguish between anxiety-induced sweating and prWeighing the Role of Network Meta-analysis for Choosing Biologic Therapies in Psoriatic Disease
https://practicaldermatology.com/programs/practical-dermatology/weighing-the-role-of-network-meta-analysis-for-choosing-biologic-therapies-in-psoriatic-disease/18189/There’s no paucity of studies for biologic therapies used to treat psoriatic disease, but the number of head-to-head trials comparing these agents is limited. Enter network meta-analysis, a statistical methodology that has emerged over the past few years to compare medication. Philip Mease, MD, a clBalneotherapy Continued: A Future in US Dermatology?
https://practicaldermatology.com/series/type-ii-inflammation-journal-club/balneotherapy-continued-a-future-in-us-dermatology/54116/Practical Dermatology editorial board member Peter Lio, MD, and Karan Lal, DO, MS, FAAD, continue their discussion of the International Journal of Biometeorology article “Balneotherapy using thermal mineral water baths and dermatological diseases: a systematic review,” covering the evidence supportiCounseling Points for Patients Concerned About Long-term Immune Modulation
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37164/Practical Dermatology Editorial Board member Peter Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine, lists some of the most important counselling points for patients concerned about long-term immune modulation with newer sysScientifically Speaking: Rox Anderson, MD Talks Changing Lives Through Inventions
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-rox-anderson-md-talks-changing-lives-through-inventions/20140/Rox Anderson, MD has been at the forefront of inventions that have shaped the modern practice of dermatology. He discusses his inspirations and his desire to advance patient care. Host Joel L. Cohen, MD talks to him about his latest innovations and a recent recognition.Skin Cancer Perceptions, Cimzia for Psoriasis, Eczema and CV Risk
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-skin-cancer-perceptions-cimzia-for-psoriasis-eczema-and-cv-risk/18301/A new national survey, Skin Cancer In America 2018, conducted by Health Union, explores perceptions of patients with skin cancer. Cimzia (certolizumab pegol, UCB) has received FDA approval for treatment of adults with moderate to severe plaque psoriasis. Cimzia is the first Fc-free, PEGylated anti TConnective Tissue Disorders Update 2025: Dr. Vleugels
https://reachmd.com/programs/practical-dermatology/connective-tissue-disorders-update-2025-dr-vleugels/32673/Ruth Ann Vleugels, MD, PhD, recaps her presentation, "Connective Tissue Disorders Update 2025" at Maui Derm 2025. Dr. Vleugels discussed a new therapeutic for systemic lupus, a new FDA-approved option for dermatomyositis, JAK inhibitors, and more.